Biocept Financials

BIOCDelisted Stock  USD 1.45  0.17  13.28%   
Based on the key indicators related to Biocept's liquidity, profitability, solvency, and operating efficiency, Biocept is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.
  
Understanding current and past Biocept Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biocept's financial statements are interrelated, with each one affecting the others. For example, an increase in Biocept's assets may result in an increase in income on the income statement.
Please note, the presentation of Biocept's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biocept's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Biocept's management manipulating its earnings.

Biocept Stock Summary

Biocept competes with Ibio, Aytu BioScience, and Actinium Pharmaceuticals. Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California. Biocept operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 177 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS09072V5012
Business Address9955 Mesa Rim
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitebiocept.com
Phone858 320 8200
CurrencyUSD - US Dollar

Biocept Key Financial Ratios

Biocept Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Biocept's current stock value. Our valuation model uses many indicators to compare Biocept value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biocept competition to find correlations between indicators driving Biocept's intrinsic value. More Info.
Biocept is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biocept's earnings, one of the primary drivers of an investment's value.

Biocept Market Pulse

 Quote1.45
 Change(%)  13.28 
 Change0.17 
 Open1.28
 Low1.28
 High1.55
 Volume0
 ExchangeNASDAQ

About Biocept Financials

What exactly are Biocept Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Biocept's income statement, its balance sheet, and the statement of cash flows. Potential Biocept investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Biocept investors may use each financial statement separately, they are all related. The changes in Biocept's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biocept's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Biocept December 1, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Biocept help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biocept. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biocept based on widely used predictive technical indicators. In general, we focus on analyzing Biocept Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biocept's daily price indicators and compare them against related drivers.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in Biocept Stock

If you are still planning to invest in Biocept check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biocept's history and understand the potential risks before investing.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.